Illness	Number of cases
Malignant neoplasm of breast (C50.4)	672
Carcinoma in situ of breast (D05.1)	198
Benign neoplasm of breast (D24)	186
Malignant neoplasm of breast (C50.2)	126
Malignant neoplasm of breast (C50.5)	92
Complications of other internal prosthetic devices implants and grafts (T85.82)	76
Malignant neoplasm of breast (C50.1)	64
Malignant neoplasm of breast (C50.3)	54
Prophylactic surgery - Encounter for prophylactic removal of unspecified organ (Z40.00)	52
Malignant neoplasm of breast (C50.8)	48

Top 10 treatments

Treatment	Number
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a2)	723
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.11)	630
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer (3-760)	629
Revision operations (5-983)	316
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a1)	281
Other reconstructive operations on the breast (5-886.30)	227
(5-877.20)	164
Surgical removal of the breast (mastectomy), without taking the axillary lymph nodes (5-872.1)	161
Examination of the abdominal cavity or its organs by endoscopy (1-694)	144
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.12)	138

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Inpatient department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	2
Bezeichnung
Teilnahme externe Qualitätssicherung	2

External quality assurance according to the DMP

Brustkrebs

Das Krankenhaus Jerusalem ist durch die Behandlung von Brustkrebspatientinnen des Mamma-Zentrum Hamburg am Disease-Management-Programm Brustkrebs beteiligt, ein eigener Vertrag besteht nicht.

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
0	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)	Betreuung von Dissertationen
Participation in multi-centre Phase I/II studies	Die Onko-Kolleg Studiengesellschaft nimmt zzt. an > 50 klinischen Studien d. Phasen II - IV, nicht-interventionellen Beobachtungen u.weiteren Forschungsprojekten zur Diagnostik u. Behandlung von soliden Tumoren, Lymphomen, Leukämien, hämatologischen Erkrankungen u. supportiven Therapiezielen teil.
Participation in multi-centre phase III/IV studies	s. FL05
Editors of scientific journals/textbooks	Leitlinien AGO, Frauenheilkunde aktuell, www.senolog.de
Lectureships / teaching posts at colleges and universities